Difference between revisions of "Cerwenka A, et al, J Immunol (1999), cited as Ref 35 in DOI:10.1007/s11886-020-01292-3 (Q10544)"
Jump to navigation
Jump to search
(Created claim: Published In Name String (P102): J Immunol, #quickstatements; #temporary_batch_1592505200825) |
(Created claim: Page(s) (P105): 5535-5543, #quickstatements; #temporary_batch_1592505331951) |
||
Property / Page(s) | |||
+ | 5535-5543 | ||
Property / Page(s): 5535-5543 / rank | |||
+ | Normal rank |
Revision as of 18:36, 18 June 2020
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
Language | Label | Description | Also known as |
---|---|---|---|
English |
Cerwenka A, et al, J Immunol (1999), cited as Ref 35 in DOI:10.1007/s11886-020-01292-3
|
Cited in: "Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response" Research article published in Curr Cardiol Rep; 2020 04 21 ; 22 (5) 32.
|
Statements
Q10356 (Deleted Item)
0 references
Naive effector and memory CD8 T cells in protection against pulmonary influenza virus infection: homing properties rather than initial frequencies are crucial (English)
0 references
Cerwenka A
0 references
Morgan TM
0 references
Dutton RW
0 references
1999
0 references
J Immunol
0 references
5535-5543
0 references